Development of casein micellar pediatric formulations

Poster presented at the 1st European Conference on Pharmaceutics. 13-14 April 2015, Reims, France."The current need for medicines specifically designed for children, which consider ease of administration, dose flexibility, palatability, safety of excipients, stability and therapeutic equivalency of pediatric dosage forms, has driven the development of pediatric drug formulations. In the present work casein (CN) based micellar formulations are evaluated as vehicles for the oral delivery of pediatric drugs, since caseins are nontoxic, biodegradable, GRAS materials and nanoencapsulation of drugs can improve their bioavailability. Chemical crosslinking of casein by carbodiimide (EDC) has been studied as an approach to improve the stability of the CN micelles and to tailor drug release."Fundação para a Ciência e a Tecnologia, Portugal (Research grant PTDC/DTPFTO/1057/2012

Evaluation of the ability of powdered milk to produce mini-tablets containing paracetamol

Poster presented at the 1st European Conference on Pharmaceutics. 13-14 April 2015, Reims, France"In recent years the development of medicines for paediatric use have gained increase interest. Small, flexible solid dosage forms, such as mini-tablets, are an attractive choice when developing new medicines for children. Excipients, though innocuous in adults, may pose a threat to the different paediatric age groups and, therefore, milk, a complete, universally accepted food, used in children’s diet since birth, seems to be an innovative and attractive excipient when formulating for the aforementioned population. In this study a full factorial design was employed to identify the variables (both formulation and manufacturing) and their interactions with significant impact on selected properties of mini-tablets, containing paracetamol and powdered milk, produced by direct compression."Fundação para a Ciência e a Tecnologia (PTDC/DTP-FTO/1057/2012